SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is capturing attention as the community debates its long-term potential, driven by excitement over the LitVM ecosystem growth and ongoing speculation regarding institutional adoption. While some investors view recent price action as a consolidation period ripe for accumulation, others express frustration over its market performance compared to other crypto assets.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending as investors debate the impact of its recent integration with real-world asset tokenization initiatives versus ongoing community frustration over price performance. The conversation is dominated by intense skepticism from traders calling out 'greedy' bag holders and predicting further downward movement, while others highlight staking utility and upcoming regulatory developments as potential catalysts for a turnaround.

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

DebtReliefBot (DRB) is trending on the Base chain as investors capitalize on the narrative that Grok's AI-managed wallet has accumulated significant capital from the project. Community members are actively highlighting its connection to the Bankr ecosystem and speculating on the potential for massive growth if the token receives broader recognition or institutional engagement.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin (BNKR) is gaining traction as community members highlight its role as essential infrastructure for autonomous AI agents within the Base ecosystem. Investors are actively discussing the token's long-term utility, ongoing developer-led upgrades, and the potential for a supply shock as these agents increasingly require BNKR to fund compute operations.

Plume is the first RWAfi L1 network focused on crypto natives. We build infrastructure to make it easy to connect the real world and the crypto markets. We go against the traditional view of RWAs by changing its definition – it’s not just TradFi onchain but instead building net new crypto-first RWA use cases to the market including things like RWA derivatives/speculation, borrow/lend, yield farming, and more.  We are a permissionless EVM chain and ecosystem that is redefining and driving the RWA market forward. We do this through novel technologies that vertically integrate all the elements of RWAs into a single stack and ecosystem. Our tokenization engine, an EVM chain, compliance &amp; regulatory tooling, RWA data normalization, etc are all first class objects so that they work seamlessly together to make it easy to bring anything in the real world (assets, data, etc.) onchain.

Plume Network

Plume Network is trending as investors focus on its dedicated infrastructure for real-world asset tokenization and recent partnerships with institutional players. The community is actively discussing its potential for long-term growth, despite recent volatility, as they monitor technical breakouts and the project's ongoing integration with financial protocols.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is gaining traction as community members highlight a growing ecosystem, including the new Windy platform and upcoming airdrop events for holders. Supporters are actively discussing the project's long-term accumulation, strong supply locking mechanics, and its cultural narrative as a counterweight to other prominent memecoins.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is gaining market attention as investors react to its latest financial results, product growth, and ongoing clinical pipeline developments. The community is actively discussing the company's competitive positioning in the weight-loss and rare disease sectors, while keeping a close eye on pipeline catalysts and potential M&A activity within the broader biotech landscape.

Pool Corp. engages in the wholesale distribution of swimming pool supplies, equipment, and related leisure products. It also offers non-discretionary pool maintenance products such as chemicals and replacement parts, discretionary products like packaged pool kits, whole goods, irrigation, and landscape products, including a complete line of commercial and residential irrigation products and parts, power equipment for the professional landscape market, specialty products such as outdoor lighting, grills, and outdoor kitchen components, and golf irrigation and water management products. The company was founded in 1993 and is headquartered in Covington, LA.

Pool Corporation

Pool Corporation is facing significant investor scrutiny as high interest rates and cautious consumer spending continue to weigh on the discretionary housing and pool construction markets. The community is actively debating the stock's valuation and the sustainability of its business model, with many focusing on whether recent pullbacks represent a long-term value opportunity or signs of a broader cyclical decline.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense investor interest as the community monitors upcoming Phase 3 data readouts and potential regulatory milestones that could trigger a significant repricing. Shareholders are actively debating the timing of a potential buyout, highlighting institutional accumulation and tight share availability as key factors supporting a long-term bullish thesis.

Microchip Technology, Inc. engages in the provision of semiconductor products. It operates through the Semiconductor Products and Technology Licensing segments. The Semiconductor Products segment is involved in designing, developing, manufacturing, and marketing microcontrollers, development tools and analog, interface, mixed signal, connectivity devices, and timing products. The Technology Licensing segment offers license fees and royalties associated with technology licenses for the use of SuperFlash embedded flash and Smartbits one-time programmable technologies. The company was founded on February 14, 1989 and is headquartered in Chandler, AZ.

Microchip Technology, Inc.

Microchip Technology is attracting attention as it signals the end of a long inventory slump, buoyed by expanding demand in data centers and AI-driven infrastructure. The community is actively debating the company's value as an overlooked large-cap semiconductor play while monitoring the launch of new leveraged ETFs that are amplifying trading interest in the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)

Microbot Medical (MBOT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates

Microbot Medical (MBOT) delivered earnings and revenue surprises of +37.50% and -76.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday

Microbot Medical (NASDAQ:MBOT) will be releasing earnings after the market closes on Wednesday, May 13. (View Earnings Report at...

Cencora to Report Q2 Earnings: What's in Store for the Stock?

COR heads into Q2 earnings with expected steady specialty-driven growth, but customer losses and pricing pressures could temper results.

Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?

SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.

DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?

XRAY heads into Q1 earnings with U.S. softness, tariff pressure and transformation costs weighing on margins as investors watch for signs of stabilization.

Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality? 

InnovAge heads into fiscal Q3 earnings with strong growth momentum and margin gains, but seasonal cost pressures and fading Medicaid tailwinds may temper near-term upside.

Revvity to Report Q1 Earnings: What's in Store for the Stock?

RVTY heads into Q1 earnings with Diagnostics strength and Life Sciences stabilization, but China pressures and weak academic demand may temper near-term growth.

Microbot Medical (NASDAQ:MBOT) Cut to "Strong Sell" at Wall Street Zen

Wall Street Zen downgraded Microbot Medical from a "sell" rating to a "strong sell" rating in a research note on Saturday...

Stryker to Report Q1 Earnings: What's in Store for the Stock?

SYK heads into Q1 earnings with strong procedure demand and robotic surgery growth, but tariff and cost pressures may test margins.

Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Current Price	$2.03
Prev Close	$1.93
Open	$1.94
Dividend Yield	0.00%
50-Day Moving Average	$2.20
Beta	1.53
Avg. Volume	1.55M
PE Ratio	-7.34

52-Week High	$4.67
52-Week Low	$1.60
Market Capitalization	$136.34M
EPS (Annual)	-$0.287
Price to Book	1.84
Revenue Per Employee	$0.00

MBOT
Microbot Medical Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest MBOT News

MBOTMicrobot Medical Inc